Neurodegeneration is a condition common to many diseases, both congenital and age‐related, and to acute injury and trauma. Even as disease prevalence increases, treatments that protect, repair or regenerate neurons and their pathways remain elusive.
Read More »
New strategies are needed to rethink how we treat glaucoma to do more than just manage eye pressure — to actually restore vision by promoting the survival of retinal ganglion cells and their axons.
Read More »
The Catalyst for a Cure Vision Restoration research team is exploring and developing novel strategies to protect, repair, and replace lost retinal nerve cells and help them reconnect with the visual brain.
Read More »
Glaucoma Research Foundation awards annual research grants for creative pilot projects that hold promise.
Read More »
In this 2021 research progress report from the Glaucoma 360 Annual Gala presented on January 29, 2021, the CFC researchers provide a video update on their progress to date.
Read More »
This 40-minute recorded webinar features a presentation from Derek Welsbie, MD, PhD, a principal investigator in the Steven and Michele Kirsch Catalyst for a Cure Vision Restoration Initiative.
Read More »
Dr. La Torre’s laboratory focuses on generating retinal ganglion cells from stem cells to enhance axonal growth and cell survival and ultimately, to use these cells as donor cells for cell replacement therapies.
Read More »
The 2020 Weston Lecture featured a talk by world-renowned Harvard Medical School genetics researcher and best-selling author David Sinclair, PhD, AO.
Read More »This recorded 45-minute webinar features a presentation from Anna La Torre, PhD, a principal investigator in the Catalyst for a Cure research consortium.
Read More »
The Catalyst for a Cure Vision Restoration Team report on their latest challenges and progress to date.
Read More »
